Yijun Pan
Affiliations: | Monash University, Caulfield East, Victoria, Australia |
Google:
"Yijun Pan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pyun J, Koay H, Runwal P, et al. (2023) Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice. Pharmaceutics. 15 |
| Pan Y, Kagawa Y, Sun J, et al. (2022) Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis. Pharmaceutics. 14 |
| Newman SA, Pan Y, Short JL, et al. (2021) Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells. Pharmaceutical Research |
| Jin L, Pan Y, Tran NLL, et al. (2020) Intestinal permeability and oral absorption of selected drugs are reduced in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics |
| Low YL, Jin L, Morris ER, et al. (2020) Pioglitazone increases blood-brain barrier expression of fatty acid-binding protein 5 and docosahexaenoic acid trafficking into the brain. Molecular Pharmaceutics |
| Pan Y, Omori K, Ali I, et al. (2019) Increased expression of renal drug transporters in a mouse model of familial Alzheimer's disease. Journal of Pharmaceutical Sciences |
| McInerney MP, Pan Y, Volitakis I, et al. (2019) The effects of clioquinol on P-glycoprotein expression and biometal distribution in the mouse brain microvasculature. Journal of Pharmaceutical Sciences |
| Pan Y, Omori K, Ali I, et al. (2018) Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer's disease. Molecular Pharmaceutics |
| Pan Y, Nicolazzo JA. (2018) Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics. Advanced Drug Delivery Reviews |
| Pan Y, Morris ER, Scanlon MJ, et al. (2018) Dietary Docosahexaenoic Acid Supplementation Enhances Expression of Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier and Brain Docosahexaenoic Acid Levels. Journal of Neurochemistry |